Viral Vectors and Plasmid DNA Manufacturing Market by Product Type (Viral Vectors (Retrovirus, Lentiviruses, Adenoviruses, Adeno-Associated Viruses, and Others) and Plasmid (DNA Conjugative Plasmids, and Non-Conjugative Plasmids)), by Application (Gene and Cancer Therapies, Viral Infections, Immunotherapy, Formulation Development, and Others), and by End-User (Biotechnology Companies, Research Institutes, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018—2026

Global viral vectors and plasmid DNA manufacturing market expected to generate revenue of around USD 1860 million by 2026, growing at a CAGR of around 20% between 2018 and 2026. The viral vectors and plasmid DNA manufacturing market is fragmented into product type, application, and end-user.

20-Dec-2018 | Number of pages: 120 | Report Code: ZMR-3664 | Report Format : | Status : Published

Abstract

The report covers a forecast and an analysis of the viral vectors and plasmid DNA manufacturing market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the viral vectors and plasmid DNA manufacturing market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the viral vectors and plasmid DNA manufacturing market on a global level.

In order to give the users of this report a comprehensive view of the viral vectors and plasmid DNA manufacturing market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Viral Vectors and Plasmid DNA Manufacturing Market

The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, technology, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolio of various companies according to regions.

The study provides a decisive view of the viral vectors and plasmid DNA manufacturing market by segmenting the market based on product type, application, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. By product type, the market is segmented into viral vectors and plasmid. The viral vectors are further segmented into a retrovirus, lentiviruses, adenoviruses, adeno-associated viruses, and others. The plasmid segment includes DNA conjugative plasmids and non-conjugative plasmids. By application, the market for viral vectors and plasmid DNA manufacturing is segmented into gene and cancer therapies, viral infections, immunotherapy, formulation development, and others. By end-user, the market is segmented into biotechnology companies, research institutes, hospitals, and others. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further division into major countries including the U.S., Rest of North America, UK, Germany, France, Italy, Spain, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, Brazil, Rest of Latin America, GCC Countries, South Africa, and Rest of the Middle East and Africa. This segmentation includes the demand for viral vectors and plasmid DNA manufacturing market based on individual product type, application, and end-user in all the regions and countries.

The report also includes detailed profiles of various end players, such as Vigene Biosciences Inc., Lonza, FinVector Vision Therapies, Kaneka Corporation (Eurogentec), VGXI, Inc., VIROVEK, SIRION Biotech GmbH, Cobra Biologics, Novasep, FUJIFILM Diosynth Biotechnologies Inc., Spark Therapeutics, Inc., Genzyme Corporation, ALDEVRON, Brammer Bio, Oxford Gene Technology, and General Electric Company (GE Healthcare), among others.

This report segments the global viral vectors and plasmid DNA manufacturing market into:

Global Viral Vectors and Plasmid DNA Manufacturing Market: Product Type Analysis

  • Viral Vectors
    • Retrovirus
    • Lentiviruses
    • Adenoviruses
    • Adeno-Associated Viruses
    • Others
  • Plasmids
    • DNA Conjugative Plasmids
    • Non-Conjugative Plasmids

Global Viral Vectors and Plasmid DNA Manufacturing Market: Application Analysis

  • Gene and Cancer Therapies
  • Viral Infections
  • Immunotherapy 
  • Formulation Development
  • Others

Global Viral Vectors and Plasmid DNA Manufacturing Market: End-User Analysis

  • Biopharmaceutical Companies
  • Research Institutes
  • Others?

Global Viral Vectors and Plasmid DNA Manufacturing Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Aseptic Sampling Market by Type (Manual Aseptic Sampling and Automated Aseptic Sampling), by Technique (Off-Line Sampling, At-Line Sampling, and On-Line Sampling), by Application (Upstream Process and Downstream Process), and by End-User (Biotechnology and Pharmaceutical Manufacturers, Contract Research and Manufacturing Organizations, Research and Development Departments, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Mar-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3916 | Report Format:

The report covers a forecast and an analysis of the aseptic sampling market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the aseptic sampling...Read More

Genotyping Assay Market by Products & Services (Reagents & Kits, Genotyping Services, Instruments, and Bioinformatics), by Technology (PCR, Microarrays, Sequencing, Capillary Electrophoresis, MALDI-Tof MS, and Others), by Application (Pharmacogenomics, Diagnostics & Personalized Medicine, Animal Genetics, Agricultural Biotechnology, and Others), and by End-User (Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Research Laboratories, Academic Institutes, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Mar-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3874 | Report Format:

The report covers a forecast and an analysis of the genotyping assay market on a global and regional level. The study provides historical data from 2016 to 2018 along with forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the genotyping assay m...Read More

Bioburden Testing Market by Product Type (Instrument and Consumables), by Test Type (Anaerobic, Aerobic, Spore, and Fungi), by Application (Sterility Testing, Medical Devices, and Raw Material), and by End-User (Biotechnology, Pharma, and CMO): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Feb-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3869 | Report Format:

The report covers a forecast and an analysis of the bioburden testing market on a global and regional level. The study provides historic data for 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the bioburden ...Read More

Cancer Biological Therapy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3862 | Report Format:

Global Cancer Biological Therapy Market: Overview Biological cancer therapies use the bodys immune system, either directly or indirectly, to fight cancer or to lessen the side effects that may be caused by some cancer treatments. It is also called biotherapy or biological response modifiers.Biol...Read More

Human Milk Oligosaccharides (HMO) Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3837 | Report Format:

Global Human Milk Oligosaccharides (HMO) Market: Overview Human milk oligosaccharides (HMO) is present in human milk in the form of a complex bioactive sugar molecule. HMOs are growth substrates for certain useful bacteria. Extracting or synthesizing HMO in the formula is quite difficult as they...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.